首页> 外文期刊>The Journal of the American Board of Family Practice >Problem Drug-related Behavior and Discontinuation of Opioids Following the Introduction of an Opioid Management Program
【24h】

Problem Drug-related Behavior and Discontinuation of Opioids Following the Introduction of an Opioid Management Program

机译:引入阿片类药物管理计划后,与药物有关的行为问题和阿片类药物停药

获取原文
获取外文期刊封面目录资料

摘要

Purpose: Problem drug-related behavior (PDB) among patients on chronic opioid therapy may reflect an opioid use disorder. This study assessed PDB prevalence and the relationship between PDB and ongoing prescription of opioids at a primary care clinic that implemented a multifaceted opioid management program. Methods: A chart review of patients in a chronic opioid registry assessed prevalence of different types of PDB over 2 years, and whether opioids were prescribed during the last 3 months of the 2-year study period among patients with different levels of PDB. Results: Among 233 registry patients, 84.1% exhibited PDB; 45.5% exhibited ≥3 types of PDB. At the end of 2 years, most registry patients were still prescribed opioids, though patients with ≥3 types of PDB were less likely than those without PDB to be prescribed opioids (62.3% vs. 78.4%, P = 0.016). Conclusions: PDB was pervasive in this population of patients on chronic opioid therapy. Those with the most PDB, and thus with the greatest likelihood of opioid use disorder and its social and medical consequences, were the least likely to be prescribed opioids by the clinic after 2 years. Given the rising rates of illicit opioid use in the U.S., it is important that clinics work closely with their patients who display PDB, systematically assess them for opioid use disorder, and offer evidence-based treatment.
机译:目的:接受慢性阿片类药物治疗的患者中与药物相关的行为问题(PDB)可能反映出阿片类药物使用障碍。这项研究在实施多层面阿片类药物管理计划的基层医疗诊所评估了PDB的患病率以及PDB与正在进行的阿片类药物处方之间的关系。方法:对慢性阿片类药物登记患者的图表回顾评估了2年内不同类型PDB的患病率,以及在2年研究期的最后3个月中是否在不同PDB水平患者中开了阿片类药物。结果:233例登记患者中,有84.1%的患者表现为PDB。 45.5%的PDB≥3种。在2年末,大多数注册患者仍接受阿片类药物治疗,尽管PDB≥3种的患者比没有PDB的患者接受阿片类药物治疗的可能性更低(62.3%对78.4%,P = 0.016)。结论:PDB在接受慢性阿片类药物治疗的这一人群中普遍存在。 PDB最多的人,因此阿片类药物使用障碍及其社会和医疗后果的可能性最大,两年后,诊所开处方的阿片类药物的可能性最小。鉴于美国非法使用阿片类药物的比率不断上升,重要的是,诊所必须与显示PDB的患者密切合作,系统地评估他们的阿片类药物使用障碍,并提供循证治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号